Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Trends in Primary Treatment and Median Survival Among Women With Advanced-Stage Epithelial Ovarian Cancer in the US From 2004 to 2016

JAMA Network Open(2020)10.1001/jamanetworkopen.2020.17517Source: DataRank Database

Trends in Primary Treatment and Median Survival Among Women With Advanced-Stage Epithelial Ovarian Cancer in the US From 2004 to 2016 is a research paper published in JAMA Network Open (2020). On theSindex it has a DataRank of 0. It has been cited 53 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access53 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 6.63)OA: goldTopics (68)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Caryn M. St. Clair,June Y. Hou ORCID,F. Khoury Collado,Dawn L. Hershman ORCID,Jason D. Wright ORCID

Live enrichment

PubMed:32975569 PMC:PMC7519417 OpenAlex:https://openalex.org/W3089221884

NCATS NIH HHS

Grant: KL2 TR001874

National Institutes of Health

Grant: 5KL2TR001874-02

Institutional Career Development Core

FWCI

6.63

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://jamanetwork.com/journals/jamanetworkopen/articlepdf/2770955/knisely_2020_ld_200129_1600295011.47122.pdf

publisherhttps://jamanetwork.com/journals/jamanetworkopen/articlepdf/2770955/knisely_2020_ld_200129_1600295011.47122.pdf

journalhttps://doi.org/10.1001/jamanetworkopen.2020.17517

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32975569

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7519417

Fields of Study

Ovarian cancer diagnosis and treatmentEndometrial and Cervical Cancer TreatmentsIntraperitoneal and Appendiceal Malignancies03 medical and health sciences0302 clinical medicineAdenocarcinoma, MucinousAgedAntineoplastic AgentsCarcinoma, EndometrioidCarcinoma, Ovarian EpithelialChemotherapy, AdjuvantCohort StudiesCytoreduction Surgical ProceduresFemaleHumansMiddle AgedNeoadjuvant TherapyNeoplasm StagingNeoplasms, Cystic, Mucinous, and SerousOvarian NeoplasmsProgression-Free SurvivalSurvival Rate

MeSH Terms

Carcinoma, Ovarian EpithelialProgression-Free SurvivalAgedAntineoplastic AgentsAdenocarcinoma, MucinousFemaleHumansMiddle AgedNeoplasm StagingOvarian NeoplasmsCohort StudiesSurvival RateChemotherapy, AdjuvantCarcinoma, EndometrioidNeoplasms, Cystic, Mucinous, and SerousNeoadjuvant TherapyCytoreduction Surgical Procedures

Keywords

MedicineOvarian cancerStage (stratigraphy)ChemotherapyOncologyRandomized controlled trialInternal medicineEpithelial ovarian cancerCancerClinical trialAdjuvantOvarian NeoplasmsAntineoplastic AgentsCytoreduction Surgical ProceduresCarcinoma, Ovarian EpithelialMiddle AgedAdenocarcinoma, MucinousNeoadjuvant TherapyProgression-Free SurvivalCohort StudiesSurvival RateChemotherapy, AdjuvantResearch LetterHumansFemaleNeoplasms, Cystic, Mucinous, and SerousCarcinoma, EndometrioidAgedNeoplasm Staging

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of Timing of interval debulking surgery and postoperative chemotherapy after neoadjuvant chemotherapy in advanced epithelial ovarian cancer: a multicenter real-world study

10.6084/m9.figshare.23590609.v1figshare

Additional file 1 of Timing of interval debulking surgery and postoperative chemotherapy after neoadjuvant chemotherapy in advanced epithelial ovarian cancer: a multicenter real-world study

10.6084/m9.figshare.23590609figshare